Longevity Health Holdings, Inc. Delisted from Nasdaq, Begins Trading on OTC Markets

Strategic Insights -

Longevity Health Holdings, Inc. has been delisted from the Nasdaq Capital Market and has commenced trading on the over-the-counter (OTC) markets operated by OTC Markets Group, Inc. The delisting is effective as of September 12, 2025, following a written notice from the Nasdaq Stock Market LLC indicating that the company had not cured a previously reported deficiency with respect to Nasdaq Listing Rule 5550(b)(2). The transition to the OTC marketplace is not expected to affect the company's operations, and the company will continue to file periodic and other required reports with the U.S. Securities and Exchange Commission.

Key Takeaways:

  • Longevity Health Holdings, Inc. has been delisted from the Nasdaq Capital Market and began trading on the OTC markets on September 12, 2025.
  • The delisting was due to a deficiency with respect to Nasdaq Listing Rule 5550(b)(2), which the company had not cured by September 10, 2025.
  • The company's common stock and warrants have begun trading on the OTC marketplace under the ticker symbols XAGE and XAGEW, respectively.
  • Longevity Health Holdings, Inc. intends to pursue its previously disclosed merger with True Health Inc. and to list the combined company's securities on Nasdaq.
  • The company's operations are expected to remain unchanged, and it will continue to file reports with the U.S. Securities and Exchange Commission.
  • The company's forward-looking statements in the Form 8-K filing include expectations regarding the impact of the delisting, trading on the OTC marketplace, and the proposed merger with True Health Inc.

Statistics:

  • The company's common stock and warrants began trading on the OTC markets on September 12, 2025.
  • The company commenced trading on the OTC marketplace with a market symbol of XAGE.
  • The company's warrants have a ticker symbol of XAGEW.
  • The company's previously reported merger with True Health Inc. is ongoing, with the intention of listing the combined company's securities on Nasdaq.
  • The company's filings with the U.S. Securities and Exchange Commission will continue uninterrupted, despite the delisting from the Nasdaq Capital Market.

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

+ FORM 8-K CURRENT REPORT, dated September 12, 2025

+ Filed by Longevity Health Holdings, Inc. on September 12, 2025.

  • Longevity Health Holdings, Inc.'s Annual Report on Form 10-K, filed with the SEC on March 31, 2025.